Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening "Allies in Maternal and Newborn Care"; May 3-4, 2018.

[1]  O. Uthman,et al.  Universal antenatal screening for group B streptococcus may cause more harm than good , 2019, BMJ.

[2]  O. Ramilo,et al.  The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. , 2018, The Lancet. Infectious diseases.

[3]  J. Song,et al.  Progress toward a group B streptococcal vaccine , 2018, Human vaccines & immunotherapeutics.

[4]  I. Dieussaert,et al.  Maternal immunization: where are we now and how to move forward? , 2018, Annals of medicine.

[5]  S. Schrag,et al.  Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa , 2017, Vaccine.

[6]  S. Madhi,et al.  Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Madhi,et al.  Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Madhi,et al.  Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. Lucero,et al.  Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series , 2017, The Lancet. Global health.

[10]  M. Lucero,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study , 2017, The Lancet.

[11]  S. Straus,et al.  Low- and middle-income countries face many common barriers to implementation of maternal health evidence products. , 2016, Journal of clinical epidemiology.

[12]  M. Lipsitch,et al.  How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem? , 2016, mBio.

[13]  S. Halperin,et al.  Improving rates of maternal immunization: Challenges and opportunities , 2016, Human vaccines & immunotherapeutics.

[14]  R. Atun,et al.  Integration of antenatal care services with health programmes in low– and middle–income countries: systematic review , 2016, Journal of global health.

[15]  David Osrin,et al.  Stillbirths: rates, risk factors, and acceleration towards 2030 , 2016, The Lancet.

[16]  N. Stafford.  Alfred G Gilman , 2016, BMJ : British Medical Journal.

[17]  R. Beigi,et al.  Maternal benefits of immunization during pregnancy. , 2015, Vaccine.

[18]  H. Rees,et al.  Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. , 2015, Vaccine.

[19]  G. Kang,et al.  Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. , 2014, Vaccine.

[20]  S. Arifeen,et al.  IgA and Neutralizing Antibodies to Influenza A Virus in Human Milk: A Randomized Trial of Antenatal Influenza Immunization , 2013, PloS one.

[21]  R. Adegbola,et al.  Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. , 2012, Vaccine.

[22]  Jie Zheng,et al.  Determinants of asthma after severe respiratory syncytial virus bronchiolitis. , 2012, The Journal of allergy and clinical immunology.

[23]  U. Reddy,et al.  Infection-related stillbirths , 2010, The Lancet.

[24]  S. Omer.  Maternal Immunization. , 2017, The New England journal of medicine.